Notably, our functional assays showed that overexpression of NANOG and HOXA9 significantly promoted survival of DLBCL cells, in vivo tumorigenesis, and anchorage-independent clonogenic ability. This evidence concerns the gene NANOG and diffuse large B-cell lymphoma.